SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Anna Castrioto, Stéphane Thobois, Sebastien Carnicella, Audrey Maillet, Paul Krack, Emotional manifestations of PD: Neurobiological basis, Movement Disorders, 2016, 31, 4
  2. 2
    Jeffrey W. Cooney, Mark Stacy, Neuropsychiatric Issues in Parkinson’s Disease, Current Neurology and Neuroscience Reports, 2016, 16, 5

    CrossRef

  3. 3
    Raul Martinez-Fernandez, Pierre Pelissier, Jean-Louis Quesada, Hélène Klinger, Eugénie Lhommée, Emmanuelle Schmitt, Valerie Fraix, Stephan Chabardes, Patrick Mertens, Anna Castrioto, Andrea Kistner, Emmanuel Broussolle, Pierre Pollak, Stéphane Thobois, Paul Krack, Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease, Journal of Neurology, Neurosurgery & Psychiatry, 2016, 87, 3, 311

    CrossRef

  4. 4
    Valérie M.J. Lamberti, Bruno Pereira, Eugénie Lhommée, Amélie Bichon, Emmanuelle Schmitt, Pierre Pelissier, Andrea Kistner, Valérie Fraix, Anna Castrioto, Rianne A. J. Esselink, Frank Durif, Paul Krack, Profile of Neuropsychiatric Symptoms in Parkinson’s Disease: Surgical Candidates Compared to Controls, Journal of Parkinson's Disease, 2016, 6, 1, 133

    CrossRef

  5. 5
    R Magnard, Y Vachez, C Carcenac, P Krack, O David, M Savasta, S Boulet, S Carnicella, What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson’s disease?, Translational Psychiatry, 2016, 6, 3, e753

    CrossRef

  6. 6
    Aude Gesquière-Dando, Eric Guedj, Anderson Loundou, Romain Carron, Tatiana Witjas, Frédérique Fluchère, Marie Delfini, Laura Mundler, Jean Regis, Jean-Philippe Azulay, Alexandre Eusebio, A preoperative metabolic marker of parkinsonian apathy following subthalamic nucleus stimulation, Movement Disorders, 2015, 30, 13
  7. 7
    María Sierra, Sébastien Carnicella, Antonio P. Strafella, Amélie Bichon, Eugénie Lhommée, Anna Castrioto, Stephan Chabardes, Stéphane Thobois, Paul Krack, Amos D. Korczyn, Heinz Reichmann, K. Ray Chaudhuri, Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors, Journal of Parkinson's Disease, 2015, 5, 3, 625

    CrossRef

  8. 8
    Melina G.H.E. den Brok, Jan Willem van Dalen, Willem A. van Gool, Eric P. Moll van Charante, Rob M.A. de Bie, Edo Richard, Apathy in Parkinson's disease: A systematic review and meta-analysis, Movement Disorders, 2015, 30, 6
  9. 9
    Javier Pagonabarraga, Jaime Kulisevsky, Antonio P Strafella, Paul Krack, Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment, The Lancet Neurology, 2015, 14, 5, 518

    CrossRef

  10. 10
    Alexander Alamri, Ismail Ughratdar, Michael Samuel, Keyoumars Ashkan, Deep brain stimulation of the subthalamic nucleus in Parkinson's disease 2003–2013: Where are we another 10 years on?, British Journal of Neurosurgery, 2015, 29, 3, 319

    CrossRef

  11. 11
    Isabelle Rieu, Pablo Martinez-Martin, Bruno Pereira, Ingrid De Chazeron, Leo Verhagen Metman, Marjan Jahanshahi, Claire Ardouin, Isabelle Chéreau, Christine Brefel-Courbon, Fabienne Ory-Magne, Helene Klinger, Fleur Peyrol, Michael Schupbach, Kathy Dujardin, François Tison, Jean Luc Houeto, Paul Krack, Franck Durif, International validation of a behavioral scale in Parkinson's disease without dementia, Movement Disorders, 2015, 30, 5
  12. 12
    Karin Foerde, Erin Kendall Braun, E. Tory Higgins, Daphna Shohamy, Motivational modes and learning in Parkinson’s disease, Social Cognitive and Affective Neuroscience, 2015, 10, 8, 1066

    CrossRef

  13. 13
    Masa-aki Higuchi, Yoshio Tsuboi, Tooru Inoue, Kouzou Fukuyama, Hiroshi Abe, Yasuhiko Baba, Tatsuo Yamada, Predictors of the Emergence of Apathy After Bilateral Stimulation of the Subthalamic Nucleus in Patients with Parkinson's Disease, Neuromodulation: Technology at the Neural Interface, 2015, 18, 2
  14. 14
    M. J. Nirenberg, Preoperative factors of apathy in subthalamic stimulated Parkinson disease: A PET study, Neurology, 2015, 85, 5, 483

    CrossRef

  15. 15
    Hugo Cesar Baggio, Bàrbara Segura, Jose Luis Garrido-Millan, Maria-José Marti, Yaroslau Compta, Francesc Valldeoriola, Eduardo Tolosa, Carme Junque, Resting-state frontostriatal functional connectivity in Parkinson's disease–related apathy, Movement Disorders, 2015, 30, 5
  16. 16
    Carole Carcenac, Mathieu Favier, Yvan Vachez, Emilie Lacombe, Sébastien Carnicella, Marc Savasta, Sabrina Boulet, Subthalamic deep brain stimulation differently alters striatal dopaminergic receptor levels in rats, Movement Disorders, 2015, 30, 13
  17. 17
    Ning Zhang, Weiguo Liu, Min Ye, Alexander D. Cohen, Yingdong Zhang, The heterogeneity of non-motor symptoms of Parkinson’s disease, Neurological Sciences, 2015, 36, 4, 577

    CrossRef

  18. 18
    V. Fraix, A. Castrioto, E. Moro, P. Krack, Trattamento chirurgico della malattia di Parkinson, EMC - Neurologia, 2015, 15, 1, 1

    CrossRef

  19. 19
    E. Henry, Une expérience clinique du pramipexole chez 64 patients déprimés uni ou bipolaires suivis en ambulatoire, European Psychiatry, 2015, 30, 8, S58

    CrossRef

  20. 20
    Mayela Rodríguez-Violante, Paulina González-Latapi, Amin Cervantes-Arriaga, Daniel Martínez-Ramírez, Salvador Velázquez-Osuna, Azyadeh Camacho-Ordoñez, Apathy and associated factors in Mexican patients with Parkinson’s disease, Neurological Sciences, 2014, 35, 5, 729

    CrossRef

  21. 21
    Marina Nodel, Nikolay Yakhno, Anastasia Medvedeva, Michail Kulikov, Apathy in Parkinson disease, Frontiers in Biology, 2014, 9, 4, 324

    CrossRef

  22. 22
    Nicolas Carriere, Pierre Besson, Kathy Dujardin, Alain Duhamel, Luc Defebvre, Christine Delmaire, David Devos, Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: A magnetic resonance imaging shape analysis, Movement Disorders, 2014, 29, 7
  23. 23
    S Carnicella, G Drui, S Boulet, C Carcenac, M Favier, T Duran, M Savasta, Implication of dopamine D3 receptor activation in the reversion of Parkinson’s disease-related motivational deficits, Translational Psychiatry, 2014, 4, 6, e401

    CrossRef

  24. 24
    G Drui, S Carnicella, C Carcenac, M Favier, A Bertrand, S Boulet, M Savasta, Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson’s disease, Molecular Psychiatry, 2014, 19, 3, 358

    CrossRef

  25. 25
    Mathieu Favier, Theo Duran, Carole Carcenac, Guillaume Drui, Marc Savasta, Sebastien Carnicella, Pramipexole reverses Parkinson's disease-related motivational deficits in rats, Movement Disorders, 2014, 29, 7
  26. 26
    D. Devos, C. Moreau, D. Maltete, R. Lefaucheur, A. Kreisler, A. Eusebio, G. Defer, T. Ouk, J.-P. Azulay, P. Krystkowiak, T. Witjas, M. Delliaux, A. Destee, A. Duhamel, R. Bordet, L. Defebvre, K. Dujardin, Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial, Journal of Neurology, Neurosurgery & Psychiatry, 2014, 85, 6, 668

    CrossRef

  27. 27
    L. Ricciardi, L. Morgante, A. Epifanio, M. Zibetti, M. Lanotte, L. Lopiano, F. Morgante, Stimulation of the subthalamic area modulating movement and behavior, Parkinsonism & Related Disorders, 2014, 20, 11, 1298

    CrossRef

  28. 28
    Luisa Albuquerque, Miguel Coelho, Maurício Martins, Leonor Correia Guedes, Mário M. Rosa, Joaquim J. Ferreira, Maria Begoña Cattoni, Herculano Carvalho, A. Gonçalves Ferreira, Isabel Pavão Martins, STN-DBS does not change emotion recognition in advanced Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, 2, 166

    CrossRef

  29. 29
    Jean-François Daneault, Christian Duval, Sébastien Barbat-Artigas, Mylène Aubertin-Leheudre, Nicolas Jodoin, Michel Panisset, Abbas F. Sadikot, Subthalamic stimulation improves motor function but not home and neighborhood mobility, Movement Disorders, 2014, 29, 14
  30. 30
    Barbara Connolly, Susan H. Fox, Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson’s Disease, Neurotherapeutics, 2014, 11, 1, 78

    CrossRef

  31. 31
    Amanda-Amrita D. Lakraj, Bahman Jabbari, Duarte G. Machado, Neuronal Networks in Brain Function, CNS Disorders, and Therapeutics, 2014,

    CrossRef

  32. 32
    U. Spampinato, F. Tison, Depressione e malattia di Parkinson, EMC - Neurologia, 2013, 13, 1, 1

    CrossRef

  33. 33
    Robert Adam, Alexander Leff, Nihal Sinha, Christopher Turner, Paul Bays, Bogdan Draganski, Masud Husain, Dopamine reverses reward insensitivity in apathy following globus pallidus lesions, Cortex, 2013, 49, 5, 1292

    CrossRef

  34. 34
    Theresa A Zesiewicz, Pablo Martinez-Martin, Effects of rotigotine transdermal system on non-motor symptoms in Parkinson’s disease: an overview, Expert Review of Neurotherapeutics, 2013, 13, 12, 1329

    CrossRef

  35. 35
    Stefano Palminteri, Giulia Serra, Anne Buot, Liane Schmidt, Marie-Laure Welter, Mathias Pessiglione, Hemispheric dissociation of reward processing in humans: Insights from deep brain stimulation, Cortex, 2013, 49, 10, 2834

    CrossRef

  36. 36
    Niels Allert, Langzeiterfahrungen mit Tiefer Hirnstimulation, NeuroTransmitter, 2013, 24, 3, 34

    CrossRef

  37. 37
    Paolo Calabresi, Anna Castrioto, Massimiliano Di Filippo, Barbara Picconi, New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease, The Lancet Neurology, 2013, 12, 8, 811

    CrossRef

  38. 38
    David Devos, Caroline Moreau, Kathy Dujardin, Ioav Cabantchik, Luc Defebvre, Regis Bordet, New Pharmacological Options for Treating Advanced Parkinson’s Disease, Clinical Therapeutics, 2013, 35, 10, 1640

    CrossRef

  39. 39
    S. Thobois, E. Lhommee, H. Klinger, C. Ardouin, E. Schmitt, A. Bichon, A. Kistner, A. Castrioto, J. Xie, V. Fraix, P. Pelissier, S. Chabardes, P. Mertens, J.-L. Quesada, J.-L. Bosson, P. Pollak, E. Broussolle, P. Krack, Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil, Brain, 2013, 136, 5, 1568

    CrossRef

  40. 40
    Jean-Michel Reymann, Florian Naudet, Morgane Pihan, Stephan Saïkali, Bruno Laviolle, Danièle Bentué-Ferrer, Subthalamic nucleus modulates social and anxogenic-like behaviors, Behavioural Brain Research, 2013, 252, 356

    CrossRef

  41. 41
    Oscar Bernal-Pacheco, Genko Oyama, Kelly D. Foote, Yunfeng E. Dai, Samuel S. Wu, Charles E. Jacobson, Natlada Limotai, Pamela R. Zeilman, Janet Romrell, Nelson Hwynn, Ramon L. Rodriguez, Irene A. Malaty, Michael S. Okun, Taking a Better History for Behavioral Issues Pre- and Post-Deep Brain Stimulation: Issues Missed by Standardized Scales, Neuromodulation: Technology at the Neural Interface, 2013, 16, 1
  42. 42
    Günther Deuschl, Steffen Paschen, Karsten Witt, Brain Stimulation, 2013,

    CrossRef

  43. 43
    Anna Castrioto, Jens Volkmann, Paul Krack, Brain Stimulation, 2013,

    CrossRef

  44. 44
    K. Dujardin, L. Defebvre, Apathie et maladie de Parkinson : aspects cliniques, physiopathologie et évaluation, Revue Neurologique, 2012, 168, 8-9, 598

    CrossRef

  45. 45
    C. Lozachmeur, D. Drapier, Apathie et stimulation cérébrale profonde dans la maladie de Parkinson, Revue Neurologique, 2012, 168, 8-9, 620

    CrossRef

  46. 46
    Sergio E. Starkstein, Apathy in Parkinson's disease: Diagnostic and etiological dilemmas, Movement Disorders, 2012, 27, 2
  47. 47
    R. Levy, Apathy: A pathology of goal-directed behaviour. A new concept of the clinic and pathophysiology of apathy, Revue Neurologique, 2012, 168, 8-9, 585

    CrossRef

  48. 48
    U. Spampinato, F. Tison, Dépression et maladie de Parkinson, EMC - Neurologie, 2012, 9, 4, 1

    CrossRef

  49. 49
    Barbara S Connolly, Susan H Fox, Drug treatments for the neuropsychiatric complications of Parkinson’s disease, Expert Review of Neurotherapeutics, 2012, 12, 12, 1439

    CrossRef

  50. 50
    Bénédicte Ballanger, Alice Poisson, Emmanuel Broussolle, Stéphane Thobois, Functional imaging of non-motor signs in Parkinson's disease, Journal of the Neurological Sciences, 2012, 315, 1-2, 9

    CrossRef

  51. 51
    S. Thobois, B. Ballanger, A. Poisson, E. Broussolle, Imagerie des signes non moteurs dans la maladie de Parkinson, Revue Neurologique, 2012, 168, 8-9, 576

    CrossRef

  52. 52
    W.M. Michael Schüpbach, Impulsivity, impulse control disorders, and subthalamic stimulation in Parkinson’s disease, Basal Ganglia, 2012, 2, 4, 205

    CrossRef

  53. 53
    Anne Marie Bonnet, Marie France Jutras, Virginie Czernecki, Jean Christophe Corvol, Marie Vidailhet, Nonmotor Symptoms in Parkinson’s Disease in 2012: Relevant Clinical Aspects, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  54. 54
    Alfonso Fasano, Günther Deuschl, Patients and DBS targets: Is there any rationale for selecting them?, Basal Ganglia, 2012, 2, 4, 211

    CrossRef

  55. 55
    David A. Gallagher, Anette Schrag, Psychosis, apathy, depression and anxiety in Parkinson's disease, Neurobiology of Disease, 2012, 46, 3, 581

    CrossRef

  56. 56
    Benedicte Ballanger, Helene Klinger, Julien Eche, Jérôme Lerond, Anne-Evelyne Vallet, Didier Le Bars, Leon Tremblay, Véronique Sgambato-Faure, Emmanuel Broussolle, Stéphane Thobois, Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease, Movement Disorders, 2012, 27, 1
  57. 57
    Panayiota G. Michalopoulou, Adnan Azim, Derek Tracy, Sukhwinder S. Shergill, Ropinirole as an Effective Adjunctive Treatment for Clozapine-Resistant Negative Symptoms in Simple Schizophrenia, Journal of Clinical Psychopharmacology, 2012, 32, 5, 719

    CrossRef

  58. 58
    E. Lhommee, H. Klinger, S. Thobois, E. Schmitt, C. Ardouin, A. Bichon, A. Kistner, V. Fraix, J. Xie, M. Aya Kombo, S. Chabardes, E. Seigneuret, A.-L. Benabid, P. Mertens, G. Polo, S. Carnicella, J.-L. Quesada, J.-L. Bosson, E. Broussolle, P. Pollak, P. Krack, Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours, Brain, 2012, 135, 5, 1463

    CrossRef

  59. 59
    Naoto Kohno, Yoko Nabika, Genya Toyoda, Hirokazu Bokura, Tomoko Nagata, Shuhei Yamaguchi, The Effect of Ropinirole on Apathy and Depression After Herpes Encephalitis, Cognitive And Behavioral Neurology, 2012, 25, 2, 98

    CrossRef

  60. 60
    Alfonso Fasano, Antonio Daniele, Alberto Albanese, Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation, The Lancet Neurology, 2012, 11, 5, 429

    CrossRef

  61. 61
    Sergio E. Starkstein, Daniel Tranel, Neurobiology of Psychiatric Disorders, 2012,

    CrossRef

  62. 62
    Angelo Antonini, Ioannis U. Isaias, Giorgia Rodolfi, Andrea Landi, Francesca Natuzzi, Chiara Siri, Gianni Pezzoli, A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation, Journal of Neurology, 2011, 258, 4, 579

    CrossRef

  63. 63
    E. Lhommée, E. Schmitt, A. Bichon, P. Krack, Apathie et addictions comportementales dans la maladie de Parkinson : l’endroit et l’envers d’une même médaille ?, Pratique Neurologique - FMC, 2011, 2, 2, 123

    CrossRef

  64. 64
    Sergio E. Starkstein, Simone Brockman, Apathy and Parkinson’s Disease, Current Treatment Options in Neurology, 2011, 13, 3, 267

    CrossRef

  65. 65
    Thomas N. Chase, Apathy in Neuropsychiatric Disease: Diagnosis, Pathophysiology, and Treatment, Neurotoxicity Research, 2011, 19, 2, 266

    CrossRef

  66. 66
    Juan Carlos Martinez-Castrillo, Lydia Vela, Javier del Val, Araceli Alonso-Canovas, Nonmotor Disorders and Their Correlation With Dopamine, The Neurologist, 2011, 17, S9

    CrossRef

  67. 67
    N. Allert, C. Dohle, J.W. Horn, S. Kelm, H. Kirsch, P.N. Nolte, W. Weirich, H. Karbe, Rehabilitation von Parkinson-Patienten mit Tiefenhirnstimulation, Der Nervenarzt, 2011, 82, 4, 462

    CrossRef

  68. 68
    Gary Remington, Ofer Agid, George Foussias, Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment, Expert Review of Neurotherapeutics, 2011, 11, 4, 589

    CrossRef

  69. 69
    L. Kirsch-Darrow, L.B. Zahodne, M. Marsiske, M.S. Okun, K.D. Foote, D. Bowers, The trajectory of apathy after deep brain stimulation: From pre-surgery to 6 months post-surgery in Parkinson’s disease, Parkinsonism & Related Disorders, 2011, 17, 3, 182

    CrossRef

  70. 70
    V. Fraix, La maladie de Parkinson, 2011,

    CrossRef

  71. 71
    Paul Krack, Marwan I. Hariz, Christelle Baunez, Jorge Guridi, Jose A. Obeso, Deep brain stimulation: from neurology to psychiatry?, Trends in Neurosciences, 2010, 33, 10, 474

    CrossRef

  72. 72
    Mark J. Millan, From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease, Pharmacology & Therapeutics, 2010, 128, 2, 229

    CrossRef

  73. 73
    S. Thobois, C. Ardouin, E. Schmitt, E. Lhommée, H. Klinger, J. Xie, C. Lagrange, A. Kistner, M. Aya Kombo, V. Fleury, A. Poisson, V. Fraix, E. Broussolle, P. Pollak, P. Krack, Maladie de Parkinson : de la physiopathologie des troubles psychiques à la maîtrise du traitement dopaminergique, Revue Neurologique, 2010, 166, 10, 816

    CrossRef

  74. 74
    S. Thobois, E. Lhommée, H. Klinger, C. Ardouin, J. Xie, V. Fraix, A. Reilhac, A. Juphard, C. Lagrange, E. Seigneuret, P. Mertens, S. Chabardes, G. Polo, D. LeBars, M. Savasta, L. Tremblay, P. Pollak, E. Broussolle, P. Krack, Mécanismes physiopathologiques de l’apathie après stimulation du noyau sous-thalamique dans la maladie de Parkinson, Revue Neurologique, 2010, 166, S12

    CrossRef

  75. 75
    A. Fasano, L. M. Romito, A. Daniele, C. Piano, M. Zinno, A. R. Bentivoglio, A. Albanese, Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants, Brain, 2010, 133, 9, 2664

    CrossRef

  76. 76
    P. Barone, Neurotransmission in Parkinson’s disease: beyond dopamine, European Journal of Neurology, 2010, 17, 3
  77. 77
    S. Thobois, C. Ardouin, E. Lhommee, H. Klinger, C. Lagrange, J. Xie, V. Fraix, M. C. Coelho Braga, R. Hassani, A. Kistner, A. Juphard, E. Seigneuret, S. Chabardes, P. Mertens, G. Polo, A. Reilhac, N. Costes, D. LeBars, M. Savasta, L. Tremblay, J. L. Quesada, J. L. Bosson, A. L. Benabid, E. Broussolle, P. Pollak, P. Krack, Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation, Brain, 2010, 133, 4, 1111

    CrossRef

  78. 78
    S. Thobois, E. Broussolle, M. Aya Kombo, P. Pollak, P. Krack, Reply: Dopamine agonist withdrawal syndrome and non-motor symptoms after Parkinson's disease surgery, Brain, 2010, 133, 11, e156

    CrossRef

  79. 79
    Naoto Kohno, Satoshi Abe, Genya Toyoda, Hiroaki Oguro, Hirokazu Bokura, Shuhei Yamaguchi, Successful treatment of post-stroke apathy by the dopamine receptor agonist ropinirole, Journal of Clinical Neuroscience, 2010, 17, 6, 804

    CrossRef

  80. 80
    Thomas Foltynie, Marwan I Hariz, Surgical management of Parkinson’s disease, Expert Review of Neurotherapeutics, 2010, 10, 6, 903

    CrossRef

  81. 81
    M. Denheyer, Z.H. Kiss, A.M. Haffenden, Behavioral effects of subthalamic deep brain stimulation in Parkinson's disease, Neuropsychologia, 2009, 47, 14, 3203

    CrossRef

  82. 82
    H. Gervais-Bernard, J. Xie-Brustolin, P. Mertens, G. Polo, H. Klinger, D. Adamec, E. Broussolle, S. Thobois, Bilateral subthalamic nucleus stimulation in advanced Parkinson’s disease: Five year follow-up, Journal of Neurology, 2009, 256, 2, 225

    CrossRef

  83. 83
    C. Ardouin, I. Chéreau, P.-M. Llorca, E. Lhommée, F. Durif, P. Pollak, P. Krack, Évaluation des troubles comportementaux hyper- et hypodopaminergiques dans la maladie de Parkinson, Revue Neurologique, 2009, 165, 11, 845

    CrossRef

  84. 84
    Laura B. Zahodne, Shamar Young, Lindsey Kirsch-Darrow, Anne Nisenzon, Hubert H. Fernandez, Michael S. Okun, Dawn Bowers, Examination of the Lille Apathy Rating Scale in Parkinson disease, Movement Disorders, 2009, 24, 5
  85. 85
    Maria C Rodriguez-Oroz, Marjan Jahanshahi, Paul Krack, Irene Litvan, Raúl Macias, Erwan Bezard, José A Obeso, Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms, The Lancet Neurology, 2009, 8, 12, 1128

    CrossRef

  86. 86
    Holger Honig, Angelo Antonini, Pablo Martinez-Martin, Ian Forgacs, Guy C. Faye, Thomas Fox, Karen Fox, Francesca Mancini, Margherita Canesi, Per Odin, K. Ray Chaudhuri, Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life, Movement Disorders, 2009, 24, 10
  87. 87
    K Ray Chaudhuri, Anthony HV Schapira, Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment, The Lancet Neurology, 2009, 8, 5, 464

    CrossRef

  88. 88
    Barbara Borroni, Antonella Alberici, Chiara Agosti, Maura Cosseddu, Alessandro Padovani, Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy, International Psychogeriatrics, 2009, 21, 03, 463

    CrossRef

  89. 89
    Benedicte Ballanger, Marjan Jahanshahi, Emmanuel Broussolle, Stéphane Thobois, PET functional imaging of deep brain stimulation in movement disorders and psychiatry, Journal of Cerebral Blood Flow & Metabolism, 2009, 29, 11, 1743

    CrossRef

  90. 90
    V. Voon, P. Krack, A. E. Lang, A. M. Lozano, K. Dujardin, M. Schupbach, S. Thobois, F. Tamma, J. Herzog, J. Samanta, C. Kubu, H. Rossignol, Y.-Y. Poon, J. A. Saint-Cyr, C. Ardouin, E. Moro, Reply: Parkinson's disease, DBS and suicide: a role for serotonin?, Brain, 2009, 132, 10, e127

    CrossRef

  91. 91
    Dopamine withdrawal leads to apathy in patients with PD, Nature Clinical Practice Neurology, 2008, 4, 7, 349

    CrossRef

  92. 92
    Tiffini Voss, Irene Hegeman Richard, Depression in Parkinson's Disease,